These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4282801)

  • 61. Fibrin: structure and interactions.
    Hermans J; McDonagh J
    Semin Thromb Hemost; 1982 Jan; 8(1):11-24. PubMed ID: 7036348
    [No Abstract]   [Full Text] [Related]  

  • 62. Collagen matrix-bound clotting factors (CMBCF) promote healing-associated events independent of factor XIII in an in vitro model.
    Pohle T; Becker JC; Lügering A
    Wound Repair Regen; 2011 Nov; 19(6):687-92. PubMed ID: 22092839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Fibrinogen. Hereditary hypo--and dysfibrinogenemia].
    Gajdos A
    Nouv Presse Med; 1973 Apr; 2(16):1067-71. PubMed ID: 4267566
    [No Abstract]   [Full Text] [Related]  

  • 64. [Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
    Hrubisková K
    Bratisl Lek Listy; 1974; 62(1):111-9. PubMed ID: 4603642
    [No Abstract]   [Full Text] [Related]  

  • 65. A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
    He S; Johnsson H; Zabczyk M; Hultenby K; Cao H; Blombäck M
    Br J Haematol; 2013 Mar; 160(6):806-16. PubMed ID: 23360261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
    Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
    Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
    [No Abstract]   [Full Text] [Related]  

  • 67. Fibrinogen-fibrin conversion and inhibition of fibrinolysis.
    Stemberger A; Blümel G
    Thorac Cardiovasc Surg; 1982 Aug; 30(4):209-14. PubMed ID: 6182629
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Herparin and the stabilization of fibrin.
    Cuddigan BJ
    Nature; 1968 Feb; 217(5130):779-80. PubMed ID: 4966686
    [No Abstract]   [Full Text] [Related]  

  • 69. Cross-linking of actin and fibrin by fibrin-stabilizing factor.
    Mui PT; Ganguly P
    Am J Physiol; 1977 Sep; 233(3):H346-9. PubMed ID: 910923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Studies on the degradation of fibrinogen Giessen I.
    Bleyl H; Krause WH
    Thromb Res; 1976 Oct; 9(4):329-34. PubMed ID: 136059
    [No Abstract]   [Full Text] [Related]  

  • 71. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

  • 72. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 73. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 74. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 75. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Crosslinking of monomeric fibrin by factor XIIIa.
    Dardik BN; Shainoff JR
    Thromb Haemost; 1979 Oct; 42(3):864-72. PubMed ID: 505402
    [No Abstract]   [Full Text] [Related]  

  • 77. [Conversion of fibrinogen to fibrin].
    Matsuda M
    Nihon Rinsho; 1974 May; 32(5):910-4. PubMed ID: 4603434
    [No Abstract]   [Full Text] [Related]  

  • 78. [The local application of fibrinogen and collagen for hemostasis in heart surgery].
    Spängler HP; Braun F; Holle J; Moritz E; Wolner E
    Wien Med Wochenschr; 1976 Feb; 126(7):86-9. PubMed ID: 960721
    [No Abstract]   [Full Text] [Related]  

  • 79. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 80. Structure of fibrinogen and degradation products of fibrinogen and fibrin.
    Gaffney PJ
    Br Med Bull; 1977 Sep; 33(3):245-51. PubMed ID: 143980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.